Target intelligence / Profile preview

Bordetella pertussis fimbrial protein 2 and Bordetella pertussis fimbrial protein 3 (Fim2 and Fim3)

Target
Fim2 and Fim3
Molecular classification
Adhesin, Pilin, Surface appendage, Chaperone-usher family pilus, Type 1 pili family
01

Overview

Fimbrial proteins 2 and 3 are major filamentous surface proteins of Bordetella pertussis, assembled as long, helical, hair-like appendages (fimbriae) that mediate critical adherence to the ciliated epithelial cells of the respiratory tract, biofilm development, and immune evasion[1][3][5][7]. Each fimbria consists mostly of either Fim2 or Fim3 pilin subunits, whose genes (*fim2* and *fim3*) are distinct but homologous[3][5]. These proteins are essential for bacterial virulence and are key targets of the immune response as well as components of most modern acellular pertussis vaccines, where anti-fimbrial antibodies help prevent infection by inhibiting bacterial colonization[1][5][7]. Fim2 and Fim3 differ slightly in sequence, serological properties, and functional effects on biofilm formation and immune interactions[1][3][4]. Genetic variation in these loci helps diversify circulating B. pertussis strains and is useful for molecular surveillance and typing[4][5].

Other names
Fim2Fim3Type 2 fimbriaeType 3 fimbriaeBordetella pertussis fimbriaeSerotype 2 fimbriaeSerotype 3 fimbriae
02

Mechanism of action

Induced antibody response: Vaccination with Fim2/Fim3-containing vaccines generates antibodies that bind these antigens, blocking bacterial adhesion to the respiratory mucosa and thus preventing colonization and disease

03

Biological functions

Adhesion to host tissuesBiofilm formationImmune modulationColonization of host respiratory epithelium
04

Disease associations

Infection (specifically Bordetella pertussis, cause of whooping cough/pertussis)
05

Safety considerations

None specific to the target proteins. Acellular pertussis vaccines containing Fim2 and Fim3 are generally regarded as safe.
06

Interacting drugs

Acellular pertussis vaccines
07

Biomarkers

Fimbrial serotyping

Beyond the preview

Go deeper on Bordetella pertussis fimbrial protein 2 and Bordetella pertussis fimbrial protein 3 (Fim2 and Fim3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bordetella pertussis fimbrial protein 2 and Bordetella pertussis fimbrial protein 3 (Fim2 and Fim3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call